2-{(3S,4R)-4-[(3,4-dichloro-5-methyl-1H-pyrrole-2-carbonyl)-amino]-3-methoxy-piperidin-1-yl}-4-(1-methyl-1H-pyrazol-3-yl)-thiazole-5-carboxylic acid ethyl ester | 1093114-38-5

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 唑类
• 英文名称: 2-{(3S,4R)-4-[(3,4-dichloro-5-methyl-1H-pyrrole-2-carbonyl)-amino]-3-methoxy-piperidin-1-yl}-4-(1-methyl-1H-pyrazol-3-yl)-thiazole-5-carboxylic acid ethyl ester
• 英文别名: ethyl 2-[(3S,4R)-4-[(3,4-dichloro-5-methyl-1H-pyrrole-2-carbonyl)amino]-3-methoxypiperidin-1-yl]-4-(1-methylpyrazol-3-yl)-1,3-thiazole-5-carboxylate
• CAS: 1093114-38-5
• 化学式: C₂₂H₂₆Cl₂N₆O₄S
• 分子量: 541.458
• InChiKey: LYRYDEHHZMHEPV-OCCSQVGLSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.8
• 重原子数：
  35
• 可旋转键数：
  8
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.45
• 拓扑面积：
  143
• 氢给体数：
  2
• 氢受体数：
  8

文献信息

• PIPERDINE COMPOUNDS AND USES THEREOF-911
  申请人：Basarab Gregory

  公开号：US20080312255A1

  公开（公告）日：2008-12-18

  Compounds of formula (I) and their pharmaceutically acceptable salts are described. Processes for their preparation, pharmaceutical compositions containing them, their use as medicaments and their use in the treatment of bacterial infections are also described.

  描述了化合物的公式（I）及其药用盐。还描述了它们的制备过程、含有它们的药物组合物、作为药物的用途以及在治疗细菌感染中的用途。
• REDUCING CARBOHYDRATE DERIVATIVES OF ADAMANTANE AMINES, AND SYNTHESIS AND METHODS OF USE THEREOF
  申请人：Forest Laboratories, Inc.

  公开号：EP1836153A2

  公开（公告）日：2007-09-26
• Reducing carbohydrate derivatives of adamantane amines, and synthesis and methods of use thereof
  申请人：Assenza P. Sebastian

  公开号：US20060211650A1

  公开（公告）日：2006-09-21

  The present invention relates to reducing carbohydrate derivatives of adamantane amines of Formula A or pharmaceutically acceptable salts, solvates or derivatives thereof, wherein R 1 , R 2 , R 3 , and R 4 are together or separately H, F, methyl or lower alkyl, alkenyl, or alkynyl groups, and Z is derived from a mono-, di-, oligo-, or poly-saccharide that originally had an aldehyde carbonyl group. The present invention also relates to processes for the preparation of such adamantane amine derivatives, and uses of such derivatives. The compounds of the present invention are useful in the treatment of infections caused by Gram positive or Gram negative bacteria.
• [EN] REDUCING CARBOHYDRATE DERIVATIVES OF ADAMANTANE AMINES, AND SYNTHESIS AND METHODS OF USE THEREOF<br/>[FR] REDUCTION DE DERIVES DE CARBOHYDRATES D'AMINES D'ADAMANTANE, SYNTHESE ET PROCEDES D'UTILISATION AFFERENTS
  申请人：FOREST LABORATORIES

  公开号：WO2006066006A2

  公开（公告）日：2006-06-22

  [EN] The present invention relates to reducing carbohydrate derivatives of adamantane amines of Formula (A) or pharmaceutically acceptable salts, solvates or derivatives thereof, wherein R₁, R₂, R₃, and R₄ are together or separately H, F, methyl or lower alkyl, alkenyl, or alkynyl groups, and Z is derived from a mono-, di-, oligo-, or poly-saccharide that originally had an aldehyde carbonyl group. The present invention also relates to processes for the preparation of such adamantane amine derivatives, and uses of such derivatives. The compounds of the present invention are useful in the treatment of infections caused by Gram positive or Gram negative bacteria.
  [FR] Cette invention porte sur la réduction de dérivés de carbohydrates d'amines d'adamantane de formule (A) ou de ses sels, solvates ou dérivés pharmaceutiquement acceptables, dans laquelle R₁, R₂, R₃, et R₄ représentent ensemble ou séparément H, F, des groupes de méthyle ou d'alkyle inférieur, d'alcényle ou d'alkynyle et dans laquelle Z est dérivée d'un mono-, di-, oligo-, ou poly-saccharide qui avait au départ un groupe aldéhyde carbonyle. Cette invention concerne également des procédés de préparation desdits dérivés d'amine d'adamantane et l'utilisation de ces dérivés. Les composés décrits dans l'invention sont utiles pour le traitement d'infections causées par des bactéries gram positives ou gram négatives.